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urinesamplesfrompatientswithmucopolysaccharidoses
(sensitivity 100%). In a series of 405 urine samples offered for metabolic screening, 24 samples with increased GAG content and normal GAG composition were seen (specificity 94%). The method may also be applicable for determining GAG in otherbody fluids or solutions containing protein.
Measuring glycosaminoglycans (GAGs) in urine is generally used as a screening procedure for mucopolysaccharidoses.'
All known mucopolysaccharidoses cause increased urinary GAG (1). Screening tests can be performed on untimed urine portions by quantitative measurement of GAG concentration, which must be corrected for creatimne content (2). These tests rely on carefully established age-dependent reference values.
Spot tests are not reliable because they are qualitative and do not correct for creatimne content of the urine (3). A simple quantitative urinary screening procedure based on the dye 1,9-dimethylmethylene blue chloride (DMB) was described (2,4). This test is easier to perform than existing quantitative procedures such as turbidity assays or the carbazole test (2). The DMB procedure was originally described by Farndale eta!. (5) were from patients not suffering from mucopolysaccharidosis, which had been sent to our laboratory for metabolic screening. Urine samples containing protein, used to study the influence of urinary protein on the recovery of GAG, were obtained from the central hospital laboratory for clinical chemistry. Protein concentrations varied from 0.15 to 3.6 g/L.
Addition of Proteins
To study the influence of protein on the DMB and modified DMB assays, we added protein to HS standards and MPS-urines. Human serum albumin (HSA, no. 0145t; Koch-Light Laboratories Ltd., Coinbrook, Bucks, UK) or human IgG (no. 1-4506; Sigma Chemical Co.) was directly dissolved in the urine samples. Urinary protein added to MPS-urines was from a patient with tubular proteinuria. Corrections were made for the GAG content of this urine. Small equal volumes of this urine were freeze-dried and redissolved in equal volumes of HS standard solutions or MPS-urines to a final protein concentration of 1 g/L. To get a comparable protein/GAG ratio for the MPS-urines, we diluted them before adding protein to give a GAG concentration between 50 and 100 mgfL.
Statistics
Methods were compared and checked for linearity according to the linear-regression procedure for methodcomparison studies, as described by Passing and Bablok
Results

Influence of Protein on DMB Assay
The influence of protein on a group of non-MPS-urmnes sent for metabolic screening (for the age category 0-1 year) is shown in (Figure 1 A-C) . C Means for the various protein groups after the DMB procedure were significantlydifferent (P = 0.0001).
d Means for the various protein groups after the DMB-Tns procedure were not significantlydifferent.
Recovery of HS in the Presence of Protein with the DMB-Tns Assay
To overcome the negative effect of protein on the results of the DMB procedure, we changed the pH and the buffer composition, which allowed the determination of GAG in the presence of relatively large protein concentrations. With the modified procedure, we obtained correct results for HS standards solubilized in urine to which protein had been added (HSA or IgG) at cdncentrations as great as 5 g/L and in urine samples from patients with proteinuria. From Figure 1 , it is clear that the effect of albumin on the DMB assay is much more pronounced than that of IgG.
Recovery of UrinaryGAG in the Presence of Protein
To check whether the modified procedure is able to overcome the effect of protein on the determination of urinary GAGs, we added protein to urine samples from mucopolysaccharidosis patients. HSA or urinary protein was dissolved in MPS-urines to a final concentration of 1 g/L. As expected, the DMB procedure gave, for all the samples containing protein, values that were too small. Values obtained with the DMB-Tris procedure correlated very well with those measured in the urine samples before protein was added (Figure 1 D) .
Correlation Between Procedures
To minimize the effect of endogenous urinary protein, we used MPS-urines with the highest GAG concentrations (150-500 mg/L) to study the correlation between the DMB and the DMB-Tris procedures. We calculated the following linear correlation and coefficient of correlation (r) (6): Reference values for the DMB-Tris assay for various age groups were, as for the DMB assay, age dependent, especially at early ages (Table 2) . Patient values are considered to be increased when the GAG content is greater than the mean value plus 2 SDs. No falsenegative results were obtained with the DMB-Tris procedure in the group of 26 MPS-urines (specificity 100%). When GAG is increased during screening for mucopolysaccharidoses, we usually perform a one-dimen. sent for metabolic screening, 24 (5.9%) false-positive results (i.e., normal composition of urinary GAGS) were obtained. For the original DMB procedure in the same series, 5.4% false-positive results were noted.
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CLINICALCHEMISTRY
Stability of Color
The original DMB reagent is stable for months. The DMB-Tris reagent is less stable and has to be prepared just before use. The decrease in color of the DMB-Tris reagent is -4% in 15 mm. Furthermore, there is a known instability of the complexes between GAGS and metachromatic dyes (2, 7) formed in the color reaction. We measured absorbance at 520 nm of the DMB-Tris color reagent for various HS concentrations and for GAGS from MPS-urines.
A decrease in absorbance of 0-5% in 15 mm was observed.
The stability of the GAG-DMB complexes under the conditions described here is comparable with the original DMB procedure.
Coefficient of Variation
The within-run CV was determined by measuring GAG concentrations in two series of 10 identical urine samples. The CV varied from 2% to 6% (GAG concentration varying between 22 and 67 mgfL). The betweenrun CV was estimated from two urine samples measured in 23 runs, and was 6-7% (GAG concentrations 56-72 mgfL).
DIscussIon
Influenceof Protein
Protein interferes with the DMB procedure. The effect of protein on the DMB assay was already described by Farndale et al. (7) for culture medium containing 100 mL of rabbit serum per liter. The influence of protein on other types of GAG determinations cannot be excluded. Poulsen (8), for example, showed that proteinuria >0.5 g/L causes a decrease in precipitation yield of GAG. Several GAG assays, e.g., the Alcian Blue (9), turbidity measurement (10), and the carbazole (11) tests, rely on GAG precipitation. We noticed an interference of urinary protein on the DMB assay at almost physiological urinary protein concentrations (Table 1) . Measurements of HS were decreased by 20% when the HSA concentration was increased from 0 to 0.08 g/L (Figure 1 A) (Figure 1 ). This effect is much more pronounced for HSA than for IgG (compare Figure 1, A and B) .
In a series of 400 urine samples, 43 had protein concentrations >0.1 gIL, stressing the importance of a technique for metabolic screening that is not disturbed by protein. In addition, such a technique would be applicable to direct measurement of GAG in other biological fluids and samples.
The modified procedure completely abolished the effect of protein (Figure 1) . The original procedure differs from the modified procedure with respect to pH (pH 8.8) and ionic strength (0.18 mol/L Tris). Glycosaininoglycan assays are mostly performed under acidic conditions.
The assays for GAG are based on the interaction of the negatively charged GAGS with a positively charged reagent: catiomc detergents such as cetylpyridinium Fhloride or cetyltrimethylammonium bromide in turbidity-measurement procedures or positively charged color reagents such as Toluidine blue, Azure A, and DMB in spectrophotometric assays. Acidic pHs are chosen to prevent interactions of other polyanions such as hyaluronic acid, DNA, or RNA with the reagent (5, 7, 12) . Under these acidic conditions, however, basic groups in proteins become positively charged and can interact with the GAG, preventing their interaction with the positively charged dye. This may explain why values that are too small are found with the original procedure when protein is present. The DMB-Tris is performed at pH 8.8. At this pH most of the urinary proteins will be negatively charged; this and possibly also the higher ionic strength of the system make the GAG available for interaction with the dye.
Correlation with Original Procedure
Concentration values and values based on creatinine content measured with the DMB-Tris procedure were -1.4-fold greater for non-MPS-urines but equal for MPS-urines with GAG concentrations >150 mg/L. This can be explained if we assume that in the non-MPSurines a substantial part of the GAG is not measured because of the normal urinary protein content. Disturbance by protein will be dependent on the GAG/protein ratio. In the MPS-urines with a much higher ratio, the influence of protein on the original procedure will be much less. The influence of urinary protein can be estimated from experiments in which increasing amounts of protein were added to GAG-containing solutions (Figure 1 A) . We estimated that at small liSA concentrations as much as -250 of GAG per 1 mg of added protein was missed by the original procedure. The amount of protein excreted per 1 mmol creatinine is variable and age-dependent but is, for example, -10 mg/mmol creatinine for children from 3 to 4 years of age (13). About 2.5 mg GAG/mmol creatinine would be missed at this protein content. Reference values for original and modified procedure at this age are 9.8 and 14.5 mg GAGImmol creatinine, respectively (ref . 2 and  Table 2 ). Differences between the two methods can therefore be explained to a great extent by the influence of protein. Although reference values are higher for the modified procedure, the percent SDs (CVs) for the various age groups are similar by both procedures (data not shown). The reliability of the DMB-Tris procedure appeared to be comparable with that of the DMB procedure. All mucopolysaccharidosis patients were detected by both procedures, and the percentage of false-positive results was comparable (5.9% and 5.4% for the DMBTris and DMB assays, respectively).
In summary, the original DMB procedure was made suitable with only a minor modification for measuring GAG concentration in urine samples with increased protein content. Good correlation was found with the original procedure both for non-MPS-urines and for 26 MPS-urines. With this new procedure it may be possible to measure GAG in protein-containing fluids such as cerebrospinal fluid, amniotic fluid, tissue culture medium, and synovial fluid. However, because of the high pH, interference by polyanions such as DNA, RNA, and hyaluronic acid must be considered.
